Lingjun Li
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Natural product bioactivities and synthesis 2
- RNA Interference and Gene Delivery 2
-
- Nanoparticle-Based Drug Delivery 5
- Co-authors
- Yingzi Wang (1 shared paper)Chunchao Han (1 shared paper)Xiaoqing Cai (3 shared papers)Yue Sun (2 shared papers)Yuzhen Wang (2 shared papers)Yongqing Zhang (2 shared papers)Zengjun Fang (2 shared papers)Lei Shi (1 shared paper)
- Journals
- International Journal of Pharmaceutics (2 papers)International Journal of Nanomedicine (2 papers)Journal of Colloid and Interface Science (1 paper)RSC Advances (1 paper)International Journal of Biological Macromolecules (1 paper)
- Partner nations
- China
In The Last Decade
Lingjun Li
19 papers receiving 346 citations
Peers
Comparison fields: 5 of 88
- Pharmaceutical Science 63
- Biomaterials 73
- Pharmacology 29
- Complementary and alternative medicine 27
- Molecular Medicine 15
Countries citing papers authored by Lingjun Li
This map shows the geographic impact of Lingjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjun Li more than expected).
Fields of papers citing papers by Lingjun Li
This network shows the impact of papers produced by Lingjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjun Li. The network helps show where Lingjun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingjun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 58 | |
| 2 | 2019 | 56 | |
| 3 | 2019 | 46 | |
| 4 | 2020 | 46 | |
| 5 | 2020 | 41 | |
| 6 | 2024 | 30 | |
| 7 | 2016 | 11 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 9 | |
| 10 | 2003 | 8 | |
| 11 | 2019 | 8 | |
| 12 | [Chemical constituents from roots of Platycodon grandiflorum]. | 2006 | 7 |
| 13 | 2024 | 5 | |
| 14 | 2016 | 5 | |
| 15 | 2024 | 4 | |
| 16 | 2025 | 3 | |
| 17 | 2024 | 3 | |
| 18 | 2025 | 1 | |
| 19 | 2014 | 1 | |
| 20 | 2025 | 0 |
About Lingjun Li
Lingjun Li is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Complementary and alternative medicine and Pharmacology, having authored 20 papers that have together received 352 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (5 papers), Traditional Chinese Medicine Analysis (3 papers), Advanced Nanomaterials in Catalysis (3 papers), Natural product bioactivities and synthesis (2 papers), Graphene and Nanomaterials Applications (2 papers), RNA Interference and Gene Delivery (2 papers) and Horticultural and Viticultural Research (1 paper). The work is most often cited by research in Pharmaceutical Science (63 citations), Biomaterials (73 citations), Pharmacology (29 citations), Complementary and alternative medicine (27 citations) and Molecular Medicine (15 citations). Lingjun Li has collaborated with scholars based in China. Frequent co-authors include Yingzi Wang, Chunchao Han, Xiaoqing Cai, Yue Sun, Yuzhen Wang, Yongqing Zhang, Zengjun Fang, Lei Shi, Peng Fei Gao and Li Zhang. Their work appears in journals such as International Journal of Pharmaceutics, International Journal of Nanomedicine, Journal of Colloid and Interface Science, RSC Advances and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.